Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids

Keyphrases

• Polyunsaturated Fatty Acids 100%
• Nutrigenetics 100%
• Nutrigenomics 100%
• Fatty Acids 57%
• Dietary Fatty Acids 57%
• Cardiovascular Disease 42%
• Genetic Variation 28%
• Gene Expression 14%
• Chronic Disease 14%
• Signaling Pathway 14%
• Metabolism 14%
• Health Benefits 14%
• In(III) 14%
• Acid Response 14%
• Arachidonic Acid 14%
• Polymorphism 14%
• Etiology 14%
• Single nucleotide Polymorphism 14%
• Human Disease 14%
• Gene Regulation 14%
• Metabolic Pathway 14%
• Prostaglandins 14%
• Liver X Receptor 14%
• Beneficial Effects 14%
• Linoleic Acid 14%
• Nuclear Receptor 14%
• α-linolenic Acid 14%
• Retinoid X Receptor 14%
• Endogenous Ligand 14%
• Receptor 2 14%
• Peroxisome Proliferator-activated Receptor 14%
• Docosahexaenoic Acid 14%
• Eicosapentaenoic Acid 14%
• Biological Response 14%
• Leukotriene B4 (LTB4) 14%
• Farnesoid X Receptor 14%
• Dietary Ligands 14%
• Cognate Receptors 14%
• Nutritional Effects 14%
• Fatty Acid Desaturase 14%
• Thromboxane 14%
• Resolvins 14%

Biochemistry, Genetics and Molecular Biology

• Nutritional Genomics 100%
• Polyunsaturated Fatty Acid 100%
• Dietary Fat 57%
• Metabolite 42%
• Gene Expression 28%
• Enzyme 28%
• Genetic Divergence 28%
• Genetic Variation 28%
• Metabolic Pathway 14%
• Single-Nucleotide Polymorphism 14%
• Gene Interaction 14%
• Liver X Receptor 14%
• Nuclear Receptor 14%
• Peroxisome Proliferator-Activated Receptor 14%
• Eicosapentaenoic Acid 14%
• Farnesoid X Receptor 14%
• Retinoid X Receptor 14%
• Leukotriene 14%
• Linolenic Acid 14%
• Prostaglandin 14%
• Fatty Acid Desaturase 14%
• Docosahexaenoic Acid 14%
• Alpha-Linolenic Acid 14%
• Thromboxane A2 14%